Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
ClinicalTrials.gov study NCT06536010. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
ClinicalTrials.gov study NCT01085656. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of rhTPO for the Treatment of Thrombocytopenia After Chemotherapy in AML Patients
ClinicalTrials.gov study NCT02267993. IPD Sharing: NO. Countries: 1. Publications: 0.
Physical Activity as Self-Management Approach to Improve Health Outcomes in AML
ClinicalTrials.gov study NCT02584296. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic CART-33 for Relapsed/Refractory CD33+ AML
ClinicalTrials.gov study NCT02799680. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid Sarcoma
ClinicalTrials.gov study NCT07028086. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AML
ClinicalTrials.gov study NCT05463640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.
ClinicalTrials.gov study NCT04275518. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
ClinicalTrials.gov study NCT05260528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Salvage Therapy With Venetoclax and Decitabine in Relapsed/Refractory AML
ClinicalTrials.gov study NCT06156579. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML
ClinicalTrials.gov study NCT05272293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
ClinicalTrials.gov study NCT06634394. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
NK Cell Therapy for AML
ClinicalTrials.gov study NCT05256277. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML
ClinicalTrials.gov study NCT06621212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
ClinicalTrials.gov study NCT07211958. IPD Sharing: NO. Countries: 2. Publications: 0.
Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS
ClinicalTrials.gov study NCT04749355. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
ClinicalTrials.gov study NCT06328179. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AML
ClinicalTrials.gov study NCT06434662. IPD Sharing: NO. Countries: 1. Publications: 0.
Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05744739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Novel Approaches to Target MECOM/EVI1 in AML
ClinicalTrials.gov study NCT05839392. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.